ArticleTargeted oncology2021

Sequential Treatment of Sorafenib-Regorafenib Versus Sorafenib-Physician's Choice: A Propensity Score-Matched Analysis.

Yeonghak Bang et al.PubMed ↗Publisher ↗

No numbers read from the abstract.